IMMUNE-MEDIATED HEPATIC DISORDER

This adverse event was reported 208 times

These drugs are most commonly taken by patients reporting IMMUNE-MEDIATED HEPATIC DISORDER:

# Drug Count
0 PEMBROLIZUMAB 149
1 NIVOLUMAB 47
2 CARBOPLATIN 42
3 AXITINIB 33
4 PEMETREXED DISODIUM 29
5 IPILIMUMAB 12
6 ATEZOLIZUMAB 7
7 CISPLATIN 7
8 ESOMEPRAZOLE MAGNESIUM 7
9 ESOMEPRAZOLE SODIUM 6
See all common drugs associated with IMMUNE-MEDIATED HEPATIC DISORDER

IMMUNE-MEDIATED HEPATIC DISORDER is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PEMBROLIZUMAB 149 0.0047
1 PLATINUM 1 0.0042
2 AXITINIB 33 0.0029
3 NALDEMEDINE 2 0.0023
4 PEMETREXED DISODIUM 29 0.0023
5 BEPOTASTINE BESILATE 1 0.0018
6 MIGLITOL 1 0.0015
7 NIVOLUMAB 47 0.0008
8 DURVALUMAB 4 0.0008
9 CARBOPLATIN 42 0.0006
See all drugs enriched for association with IMMUNE-MEDIATED HEPATIC DISORDER